Related references
Note: Only part of the references are listed.Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon
R. J. Rigby et al.
ONCOGENE (2007)
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
Willscott E. Naugler et al.
SCIENCE (2007)
Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis
Brendan J. Jenkins et al.
BLOOD (2007)
Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T
Xiaodong Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis
Louise M. Judd et al.
GASTROENTEROLOGY (2006)
Identification of protein expression signatures associated with Helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarrays
Peter Ellmark et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis
Hisanobu Ogata et al.
GASTROENTEROLOGY (2006)
IFNγ-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice
Toshikatsu Hanada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Pemetrexed and malignant pleural mesothelioma
M. Marangolo et al.
ANNALS OF ONCOLOGY (2006)
Paradoxical roles of the immune system during cancer development
KE de Visser et al.
NATURE REVIEWS CANCER (2006)
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
M Kortylewski et al.
NATURE MEDICINE (2005)
Multiple reasons for an inefficient STAT1 response upon IL-6-type cytokine stimulation
S Haan et al.
CELLULAR SIGNALLING (2005)
Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein
S Nabarro et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130
M Howlett et al.
GASTROENTEROLOGY (2005)
Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling
BJ Jenkins et al.
NATURE MEDICINE (2005)
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target
R Chiarle et al.
NATURE MEDICINE (2005)
The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis
BJ Jenkins et al.
BLOOD (2005)
Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma
Y Zavros et al.
ONCOGENE (2005)
Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer
WD Gong et al.
CLINICAL CANCER RESEARCH (2005)
The STAT3 isoforms and have unique and specific functions
D Maritano et al.
NATURE IMMUNOLOGY (2004)
Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection
G Monteleone et al.
GASTROENTEROLOGY (2004)
Interferon-γ:: an overview of signals, mechanisms and functions
K Schroder et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Imbalanced gp130-dependent signaling in macrophages alters macrophage colony-stimulating factor responsiveness via regulation of c-fms expression
BJ Jenkins et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Tissue disposition of 2 '-O-(2-methoxy) ethyl modified antisense oligonucleotides in monkeys
RZ Yu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
TH Wang et al.
NATURE MEDICINE (2004)
STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells
N Kanda et al.
ONCOGENE (2004)
IL-6-induced survival of colorectal carcinoma cells is inhibited by butyrate through down-regulation of the IL-6 receptor
H Yuan et al.
CARCINOGENESIS (2004)
Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130
LM Judd et al.
GASTROENTEROLOGY (2004)
Antisense oligonucleotide-based therapeutics for cancer
NM Dean et al.
ONCOGENE (2003)
Treatment of Helicobacter gastritis with IL-4 requires somatostatin
Y Zavros et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
PC Heinrich et al.
BIOCHEMICAL JOURNAL (2003)
Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway
M Kanai et al.
ONCOGENE (2003)
Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice
NC Tebbutt et al.
NATURE MEDICINE (2002)
Mutational switch of an IL-6 response to an interferon-γ-like response
AP Costa-Pereira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Helicobacter pylori infection and the development of gastric cancer.
N Uemura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
SOCS proteins: Negative regulators of cytokine signaling
DL Krebs et al.
STEM CELLS (2001)
TGFβ signaling in growth control, cancer, and heritable disorders
J Massagué et al.
CELL (2000)
Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130
SE Nicholson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice
XL Xu et al.
ONCOGENE (2000)
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo
R Atreya et al.
NATURE MEDICINE (2000)
Somatic mutations of the trefoil factor family 1 gene in gastric cancer
WS Park et al.
GASTROENTEROLOGY (2000)
Share Paper
